Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2019-11-11 Director's Dealing
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - Gordon 2 pages 150.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the date of change. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial performance data, management discussion, or other report types. The document length is 3476 characters, which is typical for such notices. Therefore, the correct classification is Director's Dealing (DIRS).
2019-11-11 English
Change of Director's Interest Notice - King 2 pages 151.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of shares held before and after the change, the nature of the change, and the consideration paid. This type of document is a formal notification of personal share transactions by a company director, commonly known as a director's dealing report. The document length is 3720 characters, which is typical for such notices. There is no indication that this is a full financial report, audit, or other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2019-11-11 English
Change of Director's Interest Notice - Cross 2 pages 151.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the date of change. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3545 characters, consistent with a notice rather than a full report. Therefore, the correct classification is DIRS.
2019-11-11 English
Appendix 3B and Cleansing Notice 14 pages 485.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including fully paid ordinary shares and unlisted options. It references ASX rules and provides specifics on the number of securities issued, issue price, purpose of the issue, and compliance with shareholder approval rules. The content is consistent with a formal announcement of new share issues and capital changes rather than a full financial report or earnings release. The document length is substantial (15,000 characters), and it is not merely an announcement of a report publication or a certification. Therefore, the document fits the category of a Share Issue/Capital Change announcement.
2019-11-07 English
Cellmid Share Purchase Plan Completed 1 page 73.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement regarding the completion of a Share Purchase Plan (SPP) by Cellmid Limited. It details the amount raised, the number of shares issued, and the intended use of the funds. There is no financial report, earnings data, or detailed financial statements included. The document is a specific update on a capital raising event, which fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and it is not announcing the publication of a report but providing substantive information about the financing activity itself. Therefore, the appropriate classification is CAP with high confidence.
2019-11-05 English
Cellmid Signs Trading Agreement With API/Priceline 2 pages 90.5KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement about Cellmid signing a national trading agreement with API/Priceline for the distribution of its évolis® products. It discusses the strategic importance of the agreement, expected availability, and marketing plans. There is no financial data, no mention of a report or filing, no regulatory certification, and no indication of a shareholder meeting or voting results. The document is a corporate announcement about a commercial agreement and business update. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Capital/Financing Update (CAP) since it relates to a significant business agreement impacting operations and potentially future revenue streams. Confidence is high given the clear nature of the announcement and absence of other report types.
2019-11-05 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.